NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.20+0.23 (+2.89%)
Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%
NeuroPace market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
NeuroPace's market cap was $429.22M on Nov 11, 2026, against $544.48M a year earlier. Over the last 5 years it ranged from $37.05M to $566.07M, with a median of $270.59M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $429.22M | -16.5% |
| 2025 | Dec 31, 2025 | $513.86M | +54.2% |
| 2024 | Dec 31, 2024 | $333.22M | +23.1% |
| 2023 | Dec 29, 2023 | $270.59M | +630.4% |
| 2022 | Dec 30, 2022 | $37.05M | -84.9% |
| 2021 | Dec 31, 2021 | $245.02M | – |
See a number that looks wrong?